Search Results
Mar 23, 2026, 07:00 ET Quarterhill Reports Fourth Quarter and Full Year 2025 Financial Results
margin performance from the safety and enforcement unit. Total operating expenses are comprised of selling, general, and administrative costs ("SG&A"), research and development ("R&D") costs, depreciation, amortization of intangible assets, and other charges. Total operating expenses for the
More news about: Quarterhill Inc.
Mar 22, 2026, 18:55 ET Shareholders who lost money in Shares of Camping World Holdings, Inc. (NYSE: CWH) Should Contact Wolf Haldenstein Immediately
capabilitiesFinancial health and balance sheet strengthConsumer demand and pricing conditionsOperational efficiency and SG&A improvement targetsFraud TheoryMisrepresentation of Inventory HealthCompany
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Mar 19, 2026, 14:56 ET Camping World Holdings, Inc. (CWH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Mar 19, 2026, 09:00 ET CWH Investor Alert: Camping World Holdings, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Inventory Risks: SueWallSt
complaint chronicles a pattern of alleged concealment:Management publicly committed to 600-700 basis points of SG&A improvement as a percentage of gross profit, then quietly reduced that target to 300-400 basis points, before ultimately delivering only 190 basis
More news about: SueWallSt.com
Mar 19, 2026, 08:30 ET Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
million.Selling, General and Administrative (SG&A) Expenses: SG&A expenses for the fourth quarter of 2025 were $18.5 million and were unchanged compared to the same period in 2024. Fourth quarter SG&A expenses included total non-cash share-based compensation of $3.5
More news about: Theravance Biopharma, Inc.
Mar 19, 2026, 08:30 ET Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
timeframes or at all, failure to execute stock repurchases consistent with current expectations, stock price volatility, higher than anticipated SG&A, gross margins and R&D spend, industry performance, interest rate volatility, foreign exchange rates, tax rates, the regulatory environment and
More news about: Viatris Inc.
Mar 19, 2026, 07:01 ET National Anti-Vivisection Society to host free webinar, focused on animal research ethics, on April 22
events.zoom.us/ev/AkPVdkdoAcDjD0YyokcbWzFzJeAs8qYytmytLs-339NN_BSaIV9r~Ap8O-rTbNjusmO-JKlEPsI5SS_k0DQZyyjUu4MByvlnume4X83WjAygW07MkiqFnFBmQthI34CzH0r5olP-5rTu7sg. For more information about NAVS, visit
More news about: National Anti-Vivisection Society (NAVS)
Mar 19, 2026, 07:00 ET CATO REPORTS 4Q AND FULL YEAR LOSS
offset by higher sales of markdown product. SG&A expenses decreased to 35.0% of sales in 2025 compared to 36.0% of sales in 2024. The SG&A decrease was primarily due to lower payroll costs, closed store, and impairment expenses. For the year, SG&A expenses decreased $5.0 million. Income tax
More news about: The Cato Corporation
Mar 18, 2026, 14:31 ET Camping World Holdings, Inc. (CWH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses; and (5) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading
More news about: Law Offices of Howard G. Smith
Mar 18, 2026, 09:00 ET CWH Investor Alert: Camping World Holdings, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Management Allegedly Concealed Inventory Risks: Levi & Korsinsky
complaint chronicles a pattern of alleged concealment:Management publicly committed to 600-700 basis points of SG&A improvement as a percentage of gross profit, then quietly reduced that target to 300-400 basis points, before ultimately delivering only 190 basis
More news about: Levi & Korsinsky, LLP
Mar 18, 2026, 06:50 ET Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results
of preclinical and clinical trials for certain of its other product candidates.Selling, general and administrative (SG&A) expenses were $11.7 million in 2025, a decrease of $0.5 million (4%) from $12.2 million in 2024. The decrease resulted primarily from a decrease
More news about: Protalix BioTherapeutics, Inc.
Mar 17, 2026, 18:00 ET ZTO Reports Fourth Quarter 2025 and Full Year 2025 Unaudited Financial Results
elsewhere in the core business. Combined unit sorting and transportation costs decreased 4 cents thanks to sustained productivity gain initiatives. SG&A excluding SBC as a percentage of revenue remained stable at approximately 4.4% compared to 5.0% last year. Cash flow from operating activities was
More news about: ZTO Express (Cayman) Inc.
Mar 17, 2026, 16:19 ET Sequential™ lève 3,5 millions de dollars pour construire une plateforme de découverte alimentée par l'IA pour les tests multi-omiques et les ingrédients de nouvelle génération pour la santé de la peau
maladies inflammatoires, par exemple l'acné, la dermatite atopique et la rosacée. La société a précédemment été soutenue par Innovate UK, Enterprise SG, A*STAR (Genome Institute of Singapore), SOSV, Corundum Systems Biology et d'autres organisations de premier plan.
More news about: Sequential
Mar 17, 2026, 12:18 ET Sequential™ beschafft 3,5 Millionen Dollar für den Aufbau einer KI-gestützten Entdeckungsplattform für Multi-Omic-Tests und Hautpflege-Inhaltsstoffe der nächsten Generation
innovative Lösungen für entzündliche Erkrankungen wie Akne, atopische Dermatitis und Rosazea. Das Unternehmen wurde bereits von Innovate UK, Enterprise SG, A*STAR (Genome Institute of Singapore), SOSV, Corundum Systems Biology und anderen führenden Organisationen unterstützt.
More news about: Sequential
Mar 17, 2026, 08:58 ET Sequential™ desarrollará una plataforma de descubrimiento impulsada por IA para pruebas multiómicas
está innovando en el área de enfermedades inflamatorias, como el acné, la dermatitis atópica y la rosácea. Ha recibido apoyo de Innovate UK, Enterprise SG, A*STAR (Instituto del Genoma de Singapur), SOSV, Corundum Systems Biology y otras organizaciones líderes.
More news about: Sequential
Mar 17, 2026, 06:00 ET Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
innovating in inflammatory disease areas, for example – acne, atopic dermatitis and rosacea. They have been previously supported by Innovate UK, Enterprise SG, A*STAR (Genome Institute of Singapore), SOSV, Corundum Systems Biology and other leading organisations.
More news about: Sequential
Mar 17, 2026, 02:19 ET Compal Introduces High-Density NVIDIA HGX™ Rubin NVL8 Integrated Solution at GTC 2026
GPU, supporting MoE models and large-scale training and inference workloads.Compal is introducing the SG231-2-L1, based on NVIDIA HGX Rubin NVL8. The core value of the SG231-2-L1 includes:High-Density Accelerated Architecture: Integrates eight
More news about: COMPAL ELECTRONICS,INC.
Mar 17, 2026, 02:00 ET Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
innovating in inflammatory disease areas, for example – acne, atopic dermatitis and rosacea. They have been previously supported by Innovate UK, Enterprise SG, A*STAR (Genome Institute of Singapore), SOSV, Corundum Systems Biology and other leading organisations.
More news about: Sequential
Mar 16, 2026, 22:09 ET CWH Investors Have Opportunity to Lead Camping World Holdings, Inc. Securities Fraud Lawsuit
prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses; and (5) as a result of the foregoing, defendants' positive statements about Camping World's business, operations, and prospects were materially
More news about: THE ROSEN LAW FIRM, P. A.
Mar 16, 2026, 16:15 ET Eve Holding, Inc. Reports Fourth Quarter and FY2025 Results
costs with Embraer, which performs several developmental activities for Eve, as well as engineering work with third-party suppliers.Meanwhile, SG&A increased to $7.6 million, from $6.2 million in 4Q24, mostly due to (1) an increase in the number of direct employees at Eve to approximately 200,
More news about: Eve Holding, Inc.
Mar 16, 2026, 14:56 ET CWH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Camping World Holdings (CWH) Investors of Securities Class Action Deadline on May 11, 2026
prevented it from ensuring reasonably accurate disclosures and/or guidance, including about the health of its balance sheet and/or the ability to manage SG&A expenses; and (v) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were
More news about: Faruqi & Faruqi, LLP
Mar 16, 2026, 08:52 ET Shareholders who lost money in shares of Driven Brands Holdings Inc. (NASDAQ: DRVN) should contact Wolf Haldenstein immediately
in:Overstated cash balancesOverstated revenueUnderstated selling, general and administrative (SG&A) expensesThese issues affected fiscal 2023 and 2024 financial statements.Expense Misclassification
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Mar 16, 2026, 01:25 ET Max Stock Limited Reports Fourth Quarter and Fiscal 2025 Full Year Financial Results
increase in gross margin as well as lowered tax expenses related to the closure of our operations in Portugal; these were partially offset by higher SG&A costs and Financing expenses as detailed above.Adjusted net income attributable to shareholders increased 19.5% to ILS 30.8 million in the
More news about: Max Stock Limited
Mar 12, 2026, 16:30 ET Lennar Reports First Quarter 2026 Results
homesTotal revenues of $6.6 billionHomebuilding operating earnings of $373 millionGross margin on home sales of 15.2%S,G&A expenses as a % of revenues from home sales of 9.8%Net margin on home sales of 5.3%Financial Services operating earnings
More news about: Lennar Corporation
Mar 12, 2026, 16:26 ET NetAirus Technologies Launches Panatem™ an Industry-First World-Model Artificial Intelligence Framework for Augmented Reality Headsets
Artificial Intelligence (AI) framework, which is designed for the next generation of Augmented Reality (AR), Mixed Reality (MR), and Smart Glasses (SG). Panatem™ AI introduces an autonomous AI World model that enables headsets to understand, reason, and predict real-world interactions
More news about: NetAirus Technologies